NCT07041710 Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy
| NCT ID | NCT07041710 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Médipôle Lyon-Villeurbanne |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 104 participants |
| Start Date | 2022-08-16 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 104 participants in total. It began in 2022-08-16 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Changes in taste and smell can occur during chemotherapy treatment. These chemotherapy-related side effects can negatively impact patients' quality of life and diet. The aim of this research is therefore to propose a solution to alleviate these taste and smell disorders. Based on the same principle as rehabilitation proposed for anosmia (loss of smell) related to COVID-19, we hypothesize that olfactory rehabilitation (using the sense of smell) through the odorous properties of essential oils could be effective for chemotherapy-related taste and smell alterations.
Eligibility Criteria
Inclusion Criteria: * cancer treated with chemotherapy * patient with taste and/or smell disorders Exclusion Criteria: * patient at the end of chemotherapy treatment
Frequently Asked Questions
Who can join the NCT07041710 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07041710 currently recruiting?
Yes, NCT07041710 is actively recruiting participants. Visit ClinicalTrials.gov or contact Médipôle Lyon-Villeurbanne to inquire about joining.
Where is the NCT07041710 trial being conducted?
This trial is being conducted at Villeurbanne, France.
Who is sponsoring the NCT07041710 clinical trial?
NCT07041710 is sponsored by Médipôle Lyon-Villeurbanne. The trial plans to enroll 104 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.